Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entrate totali | $3.5B | $3.4B | $3.4B | $3.0B | $2.5B | $2.4B | $2.0B | $2.1B | $1.9B | $1.8B | $1.6B | $1.6B | $1.8B | $1.8B | $1.8B | $1.7B | $1.3B | $1.1B | $1.1B | $548M | $436M |
| Utile lordo | $1.6B | $1.6B | $1.6B | $1.5B | $1.3B | $1.2B | $940M | $995M | $900M | $813M | $742M | $709M | $763M | $805M | $831M | $752M | $606M | $519M | $505M | $253M | $199M |
| Margine lordo% | 46.7% | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 47.5% | 46.0% | 46.1% | 43.6% | 42.2% | 43.8% | 46.4% | 45.6% | 46.4% | 46.5% | 45.6% | 46.2% | 45.7% |
| Risultato Operativo (EBIT) | $275M | $236M | $253M | $437M | $433M | $413M | $248M | $301M | $262M | $215M | $177M | $146M | $105M | $148M | $156M | $156M | $156M | $137M | $108M | $50M | $31M |
| Margine operativo % | 7.9% | 6.9% | 7.5% | 14.7% | 17.1% | 17.1% | 12.5% | 14.5% | 13.8% | 12.2% | 11.0% | 9.0% | 5.8% | 8.1% | 8.7% | 9.4% | 11.9% | 12.3% | 9.8% | 9.1% | 7.0% |
| Reddito netto | ($72M) | ($9M) | $113M | $427M | $297M | $277M | $158M | $197M | $180M | $79M | $154M | $102M | $57M | $80M | $78M | $92M | $95M | $81M | $65M | $32M | $18M |
| Margine netto% | -2.1% | -0.2% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 9.5% | 4.5% | 9.5% | 6.3% | 3.1% | 4.3% | 4.3% | 5.6% | 7.3% | 7.3% | 5.9% | 5.8% | 4.2% |
| EBITDA | — | $303M | $439M | $676M | $519M | $497M | $321M | $372M | $340M | $300M | $262M | $229M | $216M | $239M | $212M | $206M | $156M | $166M | $135M | $63M | $50M |
| Utile per azione (EPS) | — | $-0.06 | $0.76 | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 | $0.60 | $0.33 | $0.48 | $0.46 | $0.55 | $0.58 | $0.49 | $0.39 | $0.19 | $0.18 |
| Azioni in circolazione (M) | — | 152M | 150M | 147M | 149M | 153M | 155M | 157M | 157M | 159M | 162M | 169M | 170M | 168M | 167M | 167M | 166M | 165M | 166M | 164M | 103M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di BRKR. /companies/us/BRKR
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms